×

What are you searching for?




Pharmaceuticals

4 Min read

CELLTRION’S YEAR-END PROFIT, BIOSIMILARS DEMAND AT THE OVERSEAS MARKET

Published On 20 Feb 2020 05:00 AM


SHARE THIS ARTICLE  


Highlights –

  • Pharmaceutical giant Celltrion makes operating profit
  • Biosimilars in demand
  • Company aims to add 46 more new drugs by 2022 

South Korean pharmaceutical giant and leading drug maker Celltrion Inc. have made a consolidating operating profit in the year-end quarter of 2019. The company made a double profit in sales in comparison to its fourth-quarte....


Tags : CELLTRION, PHARMACEUTICALS, OPERATING PROFIT, BIOSIMILARS,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)